BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 20060431)

  • 1. Molecular imaging of HPMA copolymers: visualizing drug delivery in cell, mouse and man.
    Lu ZR
    Adv Drug Deliv Rev; 2010 Feb; 62(2):246-57. PubMed ID: 20060431
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HPMA copolymer-cyclic RGD conjugates for tumor targeting.
    Pike DB; Ghandehari H
    Adv Drug Deliv Rev; 2010 Feb; 62(2):167-83. PubMed ID: 19951733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. N-(2-hydroxypropyl)methacrylamide copolymer-6-(3-aminopropyl)-ellipticine conjugates. Synthesis, in vitro, and preliminary in vivo evaluation.
    Searle F; Gac-Breton S; Keane R; Dimitrijevic S; Brocchini S; Sausville EA; Duncan R
    Bioconjug Chem; 2001; 12(5):711-8. PubMed ID: 11562189
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Biodistribution of N-(2-hydroxypropyl) methacrylamide copolymer-bound mitoxantrone in mice bearing Ehrlich solid tumor].
    Huang Y; Zhang Z; Liu W
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2004 Dec; 21(6):930-4. PubMed ID: 15646335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Selective tumor-accumulation of HPMA copolymer-mitoxantrone conjugates].
    Huang Y; Zhang ZR
    Yao Xue Xue Bao; 2004 May; 39(5):374-9. PubMed ID: 15338883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overcoming the stromal barrier for targeted delivery of HPMA copolymers to pancreatic tumors.
    Buckway B; Wang Y; Ray A; Ghandehari H
    Int J Pharm; 2013 Nov; 456(1):202-11. PubMed ID: 23933441
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor targeting HPMA-porphyrin-99mTc copolymer molecular imaging agent.
    Yuan L; Ma Y; Yuan J
    J Biomater Sci Polym Ed; 2014; 25(18):2066-79. PubMed ID: 25315509
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytoplasmic delivery and nuclear targeting of synthetic macromolecules.
    Jensen KD; Nori A; Tijerina M; Kopecková P; Kopecek J
    J Control Release; 2003 Feb; 87(1-3):89-105. PubMed ID: 12618026
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural and chemical aspects of HPMA copolymers as drug carriers.
    Ulbrich K; Subr V
    Adv Drug Deliv Rev; 2010 Feb; 62(2):150-66. PubMed ID: 19931329
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Passive and active hepatoma tumor targeting of new N-(2-hydroxypropyl)methacrylamide copolymer conjugates: synthesis, characterization, and evaluation in vitro and in vivo.
    Yuan J; Yuan B; Guo H; Zeng X; Wang X; Liao S; Li J; Jia Z; Song F; Wang F
    J Biomater Sci Polym Ed; 2013; 24(12):1472-83. PubMed ID: 23829459
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improvement of anti-tumor abilities on human non-small cell lung carcinoma by micellization and cross-linking of N-(2-hydroxypropyl) methacrylamide copolymers.
    Zhou Z; Xu X; Li L; Huang Y
    J Drug Target; 2015; 23(9):821-31. PubMed ID: 25830626
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targetable HPMA copolymer-aminohexylgeldanamycin conjugates for prostate cancer therapy.
    Borgman MP; Ray A; Kolhatkar RB; Sausville EA; Burger AM; Ghandehari H
    Pharm Res; 2009 Jun; 26(6):1407-18. PubMed ID: 19225872
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeting tumor angiogenic vasculature using polymer-RGD conjugates.
    Mitra A; Mulholland J; Nan A; McNeill E; Ghandehari H; Line BR
    J Control Release; 2005 Jan; 102(1):191-201. PubMed ID: 15653145
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A novel α
    Wang F; Li L; Sun W; Li L; Liu Y; Huang Y; Zhou Z
    J Drug Target; 2018 Mar; 26(3):231-241. PubMed ID: 28792244
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeting tumor angiogenesis: comparison of peptide and polymer-peptide conjugates.
    Line BR; Mitra A; Nan A; Ghandehari H
    J Nucl Med; 2005 Sep; 46(9):1552-60. PubMed ID: 16157540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Technetium-99m-Labeled N-(2-hydroxypropyl) methacrylamide copolymers: synthesis, characterization, and in vivo biodistribution.
    Mitra A; Nan A; Ghandehari H; McNeill E; Mulholland J; Line BR
    Pharm Res; 2004 Jul; 21(7):1153-9. PubMed ID: 15290854
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improving the efficacy of combined modality anticancer therapy using HPMA copolymer-based nanomedicine formulations.
    Lammers T
    Adv Drug Deliv Rev; 2010 Feb; 62(2):203-30. PubMed ID: 19951732
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Indium-based and iodine-based labeling of HPMA copolymer-epirubicin conjugates: Impact of structure on the in vivo fate.
    Zhang L; Zhang R; Yang J; Wang J; Kopeček J
    J Control Release; 2016 Aug; 235():306-318. PubMed ID: 27266365
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetic and biodistribution studies of a bone-targeting drug delivery system based on N-(2-hydroxypropyl)methacrylamide copolymers.
    Wang D; Sima M; Mosley RL; Davda JP; Tietze N; Miller SC; Gwilt PR; Kopecková P; Kopecek J
    Mol Pharm; 2006; 3(6):717-25. PubMed ID: 17140259
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Galactosylated N-2-hydroxypropyl methacrylamide-b-N-3-guanidinopropyl methacrylamide block copolymers as hepatocyte-targeting gene carriers.
    Qin Z; Liu W; Li L; Guo L; Yao C; Li X
    Bioconjug Chem; 2011 Aug; 22(8):1503-12. PubMed ID: 21688826
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.